Optimizing dosage and duration therapy for chronic hepatitis C «difficult-to-treat patients»

by José M. Ladero
Published 2008-10-01

Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?

by José M. Ladero, María C. Cárdenas, Luis Ortega, Andrea González-Pino, Francisca Cuenca, César Morales, Anna Lee-Brunner
Published 2012-09-01

Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk

by José M Ladero, José A G Agúndez, Carmen eMartínez, Gemma eAmo, Pedro eAyuso, Elena eGarcía-Martín
Published 2012-12-01

Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C.

by Elena García-Martín, José A G Agúndez, María L Maestro, Avelina Suárez, Marta Vidaurreta, Carmen Martínez, Cristina Fernández-Pérez, Luis Ortega, José M Ladero
Published 2013-01-01

Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

by José M. Ladero, María J. Torrejón, Pilar Sánchez-Pobre, Avelina Suárez, Francisca Cuenca, Virginia de la Orden, María J. Devesa, María Rodrigo, Vicente Estrada, Gustavo López-Alonso, José A. Agúndez
Published 2013-03-01

Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease.

by José A Agúndez, Elena García-Martin, María L Maestro, Francisca Cuenca, Carmen Martínez, Luis Ortega, Miguel Carballo, Marta Vidaurreta, Marta Agreda, Gabriela Díaz-Zelaya, Avelina Suárez, Manuel Díaz-Rubio, José M Ladero
Published 2012-01-01

The relation of fibrosis stage with nutritional deficiencies and bioelectrical impedance analysis of body composition in patients with chronic hepatitis C

by Beatriz Mateos-Muñoz, Angélica Larrad-Sáinz, María J. Torrejón, María J. Devesa-Medina, María P. Matía-Martín, María C. Cárdenas, Avelina Suárez, Luis Ortega-Medina, Enrique Rey-Díaz-Rubio, José M. Ladero
Published 2016-07-01